Published in Invest Ophthalmol Vis Sci on March 01, 2006
The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol (2007) 1.37
Modified C-reactive protein might be a target autoantigen of TINU syndrome. Clin J Am Soc Nephrol (2010) 1.16
Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol (2009) 1.09
The role of complement in ocular pathology. Semin Immunopathol (2008) 1.07
The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol (2011) 0.90
Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells. Am J Pathol (2008) 0.90
Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARgamma Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin J(2). PPAR Res (2008) 0.83
Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma. Mol Immunol (2011) 0.83
CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis (2011) 0.83
Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem (2011) 0.81
Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU). Mol Immunol (2010) 0.81
Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis (2012) 0.81
Influence of molecular genetics in Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect (2014) 0.80
Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest (2010) 0.80
Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis. J Biol Chem (2009) 0.80
Association of Complement C5 Gene Polymorphisms with Proliferative Diabetic Retinopathy of Type 2 Diabetes in a Chinese Han Population. PLoS One (2016) 0.75
Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome. Sci Rep (2015) 0.75
A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization. J Cell Mol Med (2017) 0.75
The complement system in regulation of adaptive immunity. Nat Immunol (2004) 4.58
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology (1986) 3.69
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol (2005) 1.89
Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol (2001) 1.58
C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol (2004) 1.57
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med (2002) 1.41
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J (2003) 1.38
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med (2003) 1.38
Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides (2003) 1.35
C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol (2004) 1.34
Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. J Immunol (1984) 1.32
Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol (1999) 1.32
The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med (2001) 1.31
Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol (2001) 1.30
Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci (2000) 1.27
Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol (1995) 1.23
Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retinal pigment epithelium. Exp Eye Res (1991) 1.13
Complement defense mechanisms. Curr Opin Immunol (1993) 1.09
Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin Exp Immunol (1995) 1.09
Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler (2004) 1.08
The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res (2004) 1.08
Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res (1995) 1.06
Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci (1995) 1.06
L-selectin in health and disease. Resuscitation (2002) 1.05
C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology (2000) 1.03
Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol (1998) 1.02
Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest Ophthalmol Vis Sci (1997) 1.01
Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J Immunol (1995) 0.98
Complement component anaphylatoxins upregulate chemokine expression by human astrocytes. FEBS Lett (2003) 0.98
Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging (1997) 0.97
C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1. J Immunol (2004) 0.97
Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol (2004) 0.93
Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation (2002) 0.88
Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats. Infect Immun (1995) 0.86
CR3-dependent resistance to acute Toxoplasma gondii infection in mice. Infect Immun (1996) 0.85
Cytokine-based immunointervention in the treatment of autoimmune diseases. Clin Exp Immunol (2003) 0.84
Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis. Acta Neuropathol (1998) 0.83
Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res (2004) 0.82
Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp Dermatol (2005) 0.82
Cytokines and chemokines--their receptors and their genes: an overview. Adv Exp Med Biol (2003) 0.81
C5b-9 and adhesion molecules in human idiopathic membranous nephropathy. Nephrol Dial Transplant (2002) 0.79
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology (2008) 3.90
Gradient-index meta-surfaces as a bridge linking propagating waves and surface waves. Nat Mater (2012) 3.42
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.24
Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci (2004) 2.07
Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell (2009) 2.00
Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res (2005) 1.95
Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci (2010) 1.93
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol (2005) 1.89
Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.87
GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell (2009) 1.84
Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol (2007) 1.82
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest (2015) 1.74
Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2007) 1.49
Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J Immunol (2009) 1.48
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol (2006) 1.42
Functional formation of heterotypic gap junction channels by connexins-40 and -43. Channels (Austin) (2014) 1.40
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med (2003) 1.38
The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol (2007) 1.37
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol (2007) 1.31
Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem (2011) 1.29
Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci (2009) 1.29
Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells (2011) 1.29
Behavioral and anatomical abnormalities in a sodium iodate-induced model of retinal pigment epithelium degeneration. Exp Eye Res (2005) 1.29
Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. Hepatology (2011) 1.28
Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J Neuroimmunol (2008) 1.25
Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol (2009) 1.23
Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest Ophthalmol Vis Sci (2004) 1.22
Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique. Radiology (2009) 1.21
Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci (2010) 1.21
Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci (2009) 1.20
Taz-tead1 links cell-cell contact to zeb1 expression, proliferation, and dedifferentiation in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2010) 1.19
Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J Magn Reson Imaging (2009) 1.19
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci U S A (2003) 1.17
Effect of domain interaction on apolipoprotein E levels in mouse brain. J Neurosci (2005) 1.13
The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer (2009) 1.12
Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem (2003) 1.08
Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem (2004) 1.07
The role of complement in ocular pathology. Semin Immunopathol (2008) 1.07
Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet (2006) 1.06
Primary retinal detachment repair: comparison of 1-year outcomes of four surgical techniques. Retina (2011) 1.06
Uveitis referral pattern in a Midwest University Eye Center. Ocul Immunol Inflamm (2003) 1.05
Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) (2012) 1.05
Survival of allogeneic porcine retinal pigment epithelial sheets after subretinal transplantation. Invest Ophthalmol Vis Sci (2004) 1.05
Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol (2012) 1.05
Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets. J Immunol (2003) 1.05
Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer (2010) 1.05
A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. J Immunol (2005) 1.04
Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells. Invest Ophthalmol Vis Sci (2006) 1.04
Institutional care for elders in rural China. J Aging Soc Policy (2008) 1.03
Zeb1 mutant mice as a model of posterior corneal dystrophy. Invest Ophthalmol Vis Sci (2008) 1.02
Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules. Int Immunol (2003) 1.02
Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice. J Biol Chem (2010) 1.02
Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med (2013) 1.00
Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci (2004) 1.00
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol (2006) 1.00
Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther (2011) 1.00
Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest Ophthalmol Vis Sci (2009) 1.00
Regulatory effect of gammadelta T cells on IL-17+ uveitogenic T cells. Invest Ophthalmol Vis Sci (2010) 1.00
Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion. Invest Ophthalmol Vis Sci (2003) 0.99
Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. Invest Ophthalmol Vis Sci (2006) 0.99
Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice. J Immunol (2011) 0.99
Synthesis and secretion of hemoglobin by retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 0.99
CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma. PLoS One (2011) 0.99
C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice. Proc Natl Acad Sci U S A (2011) 0.98
Epigenetic and genetic alterations-based molecular classification of head and neck cancer. Expert Rev Mol Diagn (2012) 0.98
The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis. J Clin Pathol (2010) 0.98
Characterization of rat CD8+ uveitogenic T cells specific for interphotoreceptor retinal-binding protein 1177-1191. J Immunol (2004) 0.98
Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis. J Immunol (2012) 0.98
The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity. J Biol Chem (2013) 0.97
Chronic recurrent autoimmune uveitis with progressive photoreceptor damage induced in rats by transfer of IRBP-specific T cells. J Neuroimmunol (2005) 0.97
Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett (2007) 0.97
Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest Ophthalmol Vis Sci (2011) 0.97
Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. Mol Cancer (2010) 0.96
Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice. World J Gastroenterol (2000) 0.96
Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem (2011) 0.96
IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol (2011) 0.96
Effect of physician reimbursement methodology on the rate and cost of cataract surgery. Arch Ophthalmol (2005) 0.96
In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors. J Immunol (2006) 0.96
Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med (2010) 0.96